Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis

Published:2015-07 Issue:9990 Volume:386 Page:258-265
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Singh Jasvinder A,Cameron Chris,Noorbaloochi Shahrzad,Cullis Tyler,Tucker Matthew,Christensen Robin,Ghogomu Elizabeth Tanjong,Coyle Doug,Clifford Tammy,Tugwell Peter,Wells George A

Funder

Agency for Health Quality and Research Center for Education and Research on Therapeutics

National Institute of Arthritis, Musculoskeletal and Skin Diseases

National Institute of Aging

National Cancer Institute

Patient Centered Outcomes Research Institute

CIHR Drug Safety and Effectiveness Network

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Rheumatoid arthritis;Scott;Lancet,2010

2. Biologicals for rheumatoid arthritis;Tugwell;BMJ,2011

3. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis;Singh;Arthritis Care Res (Hoboken),2012

4. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update;Smolen;Ann Rheum Dis,2014

5. Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales;Ioannidis;Nat Rev Rheumatol,2013

Cited by 494 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of methotrexate plus hydroxychloroquine combination therapy vs. methotrexate monotherapy in the treatment of rheumatoid arthritis: A randomized controlled clinical trial;International Journal of Rheumatic Diseases;2024-09

2. Development of crusted scabies during biologic therapy: A systematic review;JAAD Reviews;2024-09

3. Clinical outcomes and risk factors in patients with COVID‐19 and autoimmune rheumatic diseases: insights from a major Australian hospital study;Internal Medicine Journal;2024-08-13

4. Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors;Journal of Clinical Medicine;2024-07-29

5. Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic Drugs;Drugs;2024-07-01